Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIVI III: Ocriplasmin for vitrectomy
NCT00412958Phase 2Completed
- Sponsor
- Oxurion
- Start
- Dec 2006
- Primary completion
- Oct 2008
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ocriplasmin in vitreomacular adhesion (VMA), sponsored by Oxurion. Started Dec 2006; status: completed.
02
Drugs
ocriplasmin
03
Conditions
vitreomacular adhesion (VMA)
Beyond the preview
Go deeper on NCT00412958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412958.